Company
Last deal
$12.5M
Amount
Venture - Series Unknown
Stage
06.08.2024
Date
1
all rounds
$12.5M
Total amount
General
About Company
Ambrosia Biosciences offers drug development services for small molecule-based therapies for obesity and other metabolic disorders.
Also Known As
Ambrosia
Number of employees
Company Type
For Profit
Last funding type
Venture - Series Unknown
IPO status
Private
Contacts
location
Phone number
Website URL